8-K 1 kl06027_8k.txt FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 9, 2004 ---------- SIGA Technologies, Inc. ----------------------- (Exact Name of Registrant as Specified in Charter) Delaware -------- (State or other Jurisdiction of Incorporation or Organization) 0-23047 13-3864870 ------- ---------- (Commission File (I.R.S. Employer Number) Identification Number) 420 Lexington Avenue, Suite 601 New York, New York 10170 ------------------------------- ----- (Address of Principal Executive Offices) (Zip Code) (212) 672-9100 -------------- (Registrant's telephone number, including area code) ITEM 5. Other Events and Required FD Disclosure. On June 9, 2004, SIGA Technologies, Inc., a Delaware corporation ("SIGA"), issued a press release pursuant to which SIGA announced the signing of an Asset Purchase Agreement to acquire certain antiviral programs targeting potential agents of biological warfare from ViroPharma Incorporated (VPHM) for a purchase price of $1 million in cash and 1 million shares of SIGA common stock. SIGA will purchase lead compounds, assays and scientific know-how related to development of antiviral drugs, including those targeting smallpox and hemorrhagic fever viruses such as the Ebola virus. The research programs being acquired are currently the subject of grants from the National Institutes of Health (NIH). The closing of the acquisition is subject to customary closing conditions, including obtaining approval of the transfer of the grants. For a description of the events reported pursuant to this Form 8-K, reference is made to the press release issued by SIGA on June 9, 2004, the text of which is attached hereto as Exhibit 99.1. ITEM 7. Financial Statements, Pro Forma Financial Information and Exhibits (c) Exhibits Exhibit No. Description ----------- ----------- 99.1 Press Release dated June 9, 2004. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SIGA TECHNOLOGIES, INC. By: /s/ Thomas N. Konatich -------------------------------------- Thomas N. Konatich Acting Chief Executive Officer and Chief Financial Officer Date: June 9, 2004 3 EXHIBIT INDEX Exhibit Number Description -------------- ----------- 99.1 Press Release dated June 9, 2004. 4